1 – 1 of 1
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease
Lamichhane, N. ; Melas, N. ; Bergqvist, V. LU ; Ekholm, N. P. ; Olén, O. ; Ludvigsson, J. F. ; Hjortswang, H. ; Marsal, J. LU
; Eriksson, C.
and Halfvarson, J.
(2024)
In Digestive Diseases and Sciences
69(6).
p.2175-2183
- Contribution to journal › Article